Bliss Gvs Pharma Ltd vs Gennex Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Bliss GVS Pharma Ltd is ₹ 276.25 as of 30 Apr 15:30 . The P/E Ratio of Bliss GVS Pharma Ltd changed from 14.9 on March 2021 to 14.7 on March 2025 . This represents a CAGR of -0.27% over 5 yearsThe P/E Ratio of Gennex Laboratories Ltd changed from 12.2 on March 2021 to 15.1 on March 2025 . This represents a CAGR of 4.36% over 5 years The Market Cap of Bliss GVS Pharma Ltd changed from ₹ 1018 crore on March 2021 to ₹ 1238 crore on March 2025 . This represents a CAGR of 4.00% over 5 yearsThe Market Cap of Gennex Laboratories Ltd changed from ₹ 49.46 crore on March 2021 to ₹ 274.07 crore on March 2025 . This represents a CAGR of 40.84% over 5 years The revenue of Bliss GVS Pharma Ltd for the Dec '25 is ₹ 236.71 crore as compare to the Sep '25 revenue of ₹ 252.86 crore. This represent the decline of -6.39% The revenue of Gennex Laboratories Ltd for the Dec '25 is ₹ 42.96 crore as compare to the Sep '25 revenue of ₹ 39.3 crore. This represent the growth of 9.31% The ebitda of Bliss GVS Pharma Ltd for the Dec '25 is ₹ 50.73 crore as compare to the Sep '25 ebitda of ₹ 51.94 crore. This represent the decline of -2.33% The ebitda of Gennex Laboratories Ltd for the Dec '25 is ₹ 8.27 crore as compare to the Sep '25 ebitda of ₹ 7.56 crore. This represent the growth of 9.39% The net profit of Bliss GVS Pharma Ltd changed from ₹ 22.11 crore to ₹ 24.78 crore over 7 quarters. This represents a CAGR of 6.73% The net profit of Gennex Laboratories Ltd changed from ₹ 4.66 crore to ₹ 5.99 crore over 7 quarters. This represents a CAGR of 15.43% The Dividend Payout of Bliss GVS Pharma Ltd changed from 7.64 % on March 2021 to 7.64 % on March 2025 . This represents a CAGR of 0.00% over 5 yearsThe Dividend Payout of Gennex Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bliss GVS Pharma Ltd

Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
The Company has its manufacturing facility at Palghar which is WHO GMP approved.
The business operates five cutting-edge production facilities that adhere to WHO-GMP, EU-MP, ISO 14001 and OHSAS 45001 standards. The company commenced its business in 1985.
In 1994 the company introduced a new pharmaceutical product VAGID. During the financial year ended 31 March 2014, Bliss GVS Pharma's R&D center, received approval from Government of India's Department for Scientific & Industrial Research (DSIR).

About Gennex Laboratories Ltd

Gennex Laboratories Limited, formerly known as Prudential Pharmaceuticals Limited was incorporated on June 25, 1985.
The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is in the business of Manufacturing of Bulk Drugs, Intermediates and Biotech Products.
The Company has over the years added more capacity and infrastructure by way of an additional production block and equipment to the plant to handle more products and tonnages.
The Company is having a professionally managed team at every stage of its operations. Apart from these, Gennex is among the leading Vertically Integrated' pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal.

FAQs for the comparison of Bliss GVS Pharma Ltd and Gennex Laboratories Ltd

Which company has a larger market capitalization, Bliss GVS Pharma Ltd or Gennex Laboratories Ltd?

Market cap of Bliss GVS Pharma Ltd is 2,922 Cr while Market cap of Gennex Laboratories Ltd is 242 Cr

What are the key factors driving the stock performance of Bliss GVS Pharma Ltd and Gennex Laboratories Ltd?

The stock performance of Bliss GVS Pharma Ltd and Gennex Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bliss GVS Pharma Ltd and Gennex Laboratories Ltd?

As of May 4, 2026, the Bliss GVS Pharma Ltd stock price is INR ₹276.25. On the other hand, Gennex Laboratories Ltd stock price is INR ₹9.99.

How do dividend payouts of Bliss GVS Pharma Ltd and Gennex Laboratories Ltd compare?

To compare the dividend payouts of Bliss GVS Pharma Ltd and Gennex Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.